Carcinoma, Intraductal, Noninfiltrating
"Carcinoma, Intraductal, Noninfiltrating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.
| Descriptor ID |
D002285
|
| MeSH Number(s) |
C04.557.470.200.025.275 C04.557.470.200.240.187.250 C04.557.470.615.275
|
| Concept/Terms |
Carcinoma, Intraductal, Noninfiltrating- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Intraductal
- Carcinomas, Intraductal
- Intraductal Carcinoma
- Intraductal Carcinomas
- DCIS
- Ductal Carcinoma In Situ
- Intraductal Carcinoma, Noninfiltrating
- Carcinoma, Noninfiltrating Intraductal
- Carcinomas, Noninfiltrating Intraductal
- Intraductal Carcinomas, Noninfiltrating
- Noninfiltrating Intraductal Carcinoma
- Noninfiltrating Intraductal Carcinomas
Atypical Ductal Hyperplasia- Atypical Ductal Hyperplasia
- Atypical Ductal Hyperplasias
- Ductal Hyperplasia, Atypical
- Ductal Hyperplasias, Atypical
- Hyperplasia, Atypical Ductal
- Hyperplasias, Atypical Ductal
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Intraductal, Noninfiltrating".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.025.275]
- Carcinoma in Situ [C04.557.470.200.240]
- Breast Carcinoma In Situ [C04.557.470.200.240.187]
- Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.240.187.250]
- Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
- Carcinoma, Intraductal, Noninfiltrating [C04.557.470.615.275]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Intraductal, Noninfiltrating".
This graph shows the total number of publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in this website by year, and whether "Carcinoma, Intraductal, Noninfiltrating" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 2 | 1 | 3 |
| 2006 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in Profiles.
-
Impact of Surgical Delay on Tumor Upstaging and Outcomes in Estrogen Receptor-Negative Ductal Carcinoma in Situ Patients. J Am Coll Surg. 2022 11 01; 235(5):788-798.
-
Fine-needle aspiration of intramammary lymph nodes: a clinical, radiographic, and cytologic review. J Am Soc Cytopathol. 2023 Jan-Feb; 12(1):41-47.
-
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial. J Clin Oncol. 2021 07 20; 39(21):2367-2374.
-
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43. Breast Cancer Res Treat. 2013 Nov; 142(2):415-21.
-
Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer. World J Surg Oncol. 2011 Mar 07; 9:30.
-
Twelve-month follow-up results of a trial utilizing Axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2011 Feb; 18(2):453-8.
-
High expression of obesity-linked phosphatase SHIP2 in invasive breast cancer correlates with reduced disease-free survival. Tumour Biol. 2008; 29(5):330-41.
-
Incidental discovery of bilateral breast cancer in a 24-year-old man presenting with gynecomastia. Ann Plast Surg. 2007 Jun; 58(6):673-6.
-
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod Pathol. 2006 Feb; 19(2):307-19.
-
The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries. Hum Pathol. 2005 May; 36(5):536-45.